Home PR Newswire
Friday, January 30, 2026
16.9
C
Bengaluru
Hot topics
Pharma GCCs in India — Hype, Reality & What’s Next?
Part 1: Pharma GCCs in India — Orange Markets...
First Approach in Pharma
Independence Day Special issue with Vivek Hattangadi tracing the India pharma brand story from before Independence till today.
Violence Against Medics – Lessons to Draw from Private Hospitals
One interesting fact: most medical colleges and linked public hospitals in major cities were designed in the British era, with an open ward design. A medical administrator, tongue-in-cheek, put it succinctly: “When these hospitals were designed, nobody would have imagined that doctors will face violence”.
Time for design thinking in public healthcare delivery!
Indian Pharmaceutical Innovation – Post TRIPS
It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.
Pharma GCCs – What Used to Happen in Boston or Basel Now Happens in Bangalore
GCCs - Indian Pharma moves up the Value Chain...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
Hot topics
Is Pharma Losing Good SalesPeople
Articles by Gopal Kishore, K. Hariram, Pankaj Mehrotra and Vivek Hattangadi
Biocon Bats for Affordable Insulin and Ozempic
🩺 Insulin, Innovation, and Independence: How Biocon, Civica, and...
Opportunities for Indian Pharma
Articles by Bhaskar Chakravorty, Hanno Wolfram, K. Hariram, Krishna Singh, Shreenivas S, Chandan Kumar and Salil Kallianpur
Interview with Ajit Singh, Chairman, ACG
Special interview with the Chairman of ACG and an invitation to "Pharmaceutical Marketing in the New Age" - a conference presented by ACG in partnership with MedicinMan
Pharma GCCs in India — Hype, Reality & What’s Next?
Part 1: Pharma GCCs in India — Orange Markets...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Newsletter
Get important news delivered directly to your inbox and stay connected!